(Q36349365)

13 August 2017

1 reference

title

Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

Sonsalla PK

1

1 reference

13 August 2017

Giovanni A

2

1 reference

13 August 2017

Sieber BA

3

1 reference

13 August 2017

Donne KD

4

1 reference

13 August 2017

Manzino L

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 1992

1 reference

Annals of the New York Academy of Sciences

13 August 2017

1 reference

13 August 2017

648

1 reference

13 August 2017

229-238

1 reference

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

Neuroprotective effects of adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24542.X

10.1111/J.1749-6632.1992.TB24542.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference